Evidence map›Paper›PMID 37388707›Full record

ArticleLancet regional health. Americas2023

It may take many villages, but progress can be made toward HCV elimination among people who inject drugs.

Kimberly Page

Abstract read
In one paragraph

Article in Lancet regional health. Americas, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kimberly PageDepartment of Internal Medicine, MSC10 5550, University of New Mexico Health Sciences, 1 University of New Mexico, Albuquerque, NM 87131, USA.

Funding

Tracking and EvaluationU54GM104944 · NIGMS · UNIVERSITY OF NEVADA LAS VEGAS · PI WARD, TONY JOHN · 2013 to 2023
$39.6M
Southwest Clinical Trials Node: Clinical Research and Practice to Address Substance Use in Diverse, Rural, and Underserved PopulationsUG1DA049468 · NIDA · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI MARIA ADELA GRANDO, Kimberly Page · 2019 to 2026
$12.5M
Integrative Treatment for Achieving Holistic Recovery from Comorbid Chronic Pain and Opioid Use DisorderRM1DA055301 · NIDA · UNIVERSITY OF NEW MEXICO · PI PEARSON, MATTHEW RYAN, WITKIEWITZ, KATIE A · 2021 to 2025
$10.5M
Collaborative care teams for hospitalized patients with opioid use disorders: Translating evidence into practiceU01TR002756 · NCATS · CEDARS-SINAI MEDICAL CENTER · PI DANOVITCH, ITAI, OBER, ALLISON · 2020 to 2023
$5.0M
Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventionsR01AI158666 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI Basmattee Boodram, Harel Dahari · 2022 to 2026
$3.5M
A Multi-Site Mixed Methods Study of Methamphetamine Use in the Mountain WestR01CE003356 · CE · UNIVERSITY OF NEVADA RENO · PI PAGE, KIMBERLY, WAGNER, KARLA D. · 2021 to 2023
$1.1M
NCATS NIH HHS U01 TR002756NCIPC CDC HHS R01 CE003356NIAID NIH HHS R01 AI158666NIDA NIH HHS RM1 DA055301NIDA NIH HHS UG1 DA049468NIGMS NIH HHS U54 GM104944
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37388707
PMCPMC10300567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.